Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF Tafluprost vs Combined Therapy in Glaucoma with OSD
NCT02802137Phase 4Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Mar 2015
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of tafluprost, dorzolamide, timolol in open-angle glaucoma (OAG), sponsored by Aristotle University of Thessaloniki. Started Mar 2015; status: completed.
02
Drugs
tafluprostdorzolamidetimolol
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT02802137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02802137.